Skip to content

XOMA Corporation XOMA Equity securities

Equity securities at other companies

Xencor logo
XencorXNCR
$60.57M+23.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$77.77M+76.3%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNi.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's equity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's equity securities?
XOMA Corporation (XOMA) reported equity securities of $494K in Q1 2026.
How has XOMA Corporation's equity securities changed year-over-year?
XOMA Corporation's equity securities decreased by 79.3% year-over-year, from $2.38M to $494K.
What is the long-term trend for XOMA Corporation's equity securities?
Over 4 years (2021 to 2025), XOMA Corporation's equity securities has grown at a -16.2% compound annual growth rate (CAGR), from $774K to $382K.
What does equity securities mean?
Insurance company investments in equity securities (stocks, equity funds) measured at fair value.